TNFA and IL10 Polymorphisms and IL-6 and IL-10 Levels Influence Disease Severity in Influenza A(H1N1)pdm09 Virus Infected Patients
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Subjects
2.2. Genotyping of SNPs in the Cytokine Genes
2.3. Investigation of Cytokine Levels in the Plasma of Influenza A(H1N1)pdm09 Virus Infected Cases
2.4. Statistical Analysis
3. Results
3.1. Demographic Characteristics and Disease Profile of the Study Subjects
3.2. Allele, Genotype, and Haplotype Frequencies in Influenza A(H1N1)pdm09 Virus-Infected Cases
3.3. Elevated Plasma IL-6 and IL-10 Level among Fatal Cases during the Acute Phase of Influenza A(H1N1)pdm09 Virus Infection
3.4. IL-6 and IL-10 Levels among Influenza A(H1N1)pdm09 Virus-Infected Subjects with Different Genotypes of IL-6 and IL-10
3.5. Utility of IL-6 and IL-10 Levels as A Marker for Predicting Fatality in Influenza A(H1N1)pdm09 Virus-Infected Subjects
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bhat, S.P.S.; Bhat, M.K.P.; Kumar, R.; Hosmane, G.B.; D’Sa, I. Burden of H1N1 Influenza Related Mortality in a Tertiary Care Centre. Jemds 2020, 9, 3917–3920. [Google Scholar] [CrossRef]
- Chatterjee, P.; Seth, B.; Biswas, T. Hotspots of H1N1 Influenza in India: Analysis of Reported Cases and Deaths (2010-2017). Trop. Doct. 2020, 50, 166–169. [Google Scholar] [CrossRef]
- Pérez-Rubio, G.; Ponce-Gallegos, M.A.; Domínguez-Mazzocco, B.A.; Ponce-Gallegos, J.; García-Ramírez, R.A.; Falfán-Valencia, R. Role of the Host Genetic Susceptibility to 2009 Pandemic Influenza A H1N1. Viruses 2021, 13, 344. [Google Scholar] [CrossRef]
- Short, K.R.; Veeris, R.; Leijten, L.M.; van den Brand, J.M.; Jong, V.L.; Stittelaar, K.; Osterhaus, A.D.M.E.; Andeweg, A.; van Riel, D. Proinflammatory Cytokine Responses in Extra-Respiratory Tissues During Severe Influenza. J. Infect. Dis. 2017, 216, 829–833. [Google Scholar] [CrossRef]
- Thomas, M.; Mani, R.S.; Philip, M.; Adhikary, R.; Joshi, S.; Revadi, S.S.; Buggi, S.; Desai, A.; Vasanthapuram, R. Proinflammatory Chemokines Are Major Mediators of Exuberant Immune Response Associated with Influenza A (H1N1) Pdm09 Virus Infection. J. Med. Virol. 2017, 89, 1373–1381. [Google Scholar] [CrossRef] [PubMed]
- Shi, X.; Zhou, W.; Huang, H.; Zhu, H.; Zhou, P.; Zhu, H.; Ju, D. Inhibition of the Inflammatory Cytokine Tumor Necrosis Factor-Alpha with Etanercept Provides Protection against Lethal H1N1 Influenza Infection in Mice. Crit. Care 2013, 17, R301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Warlé, M.C.; Farhan, A.; Metselaar, H.J.; Hop, W.C.J.; Perrey, C.; Zondervan, P.E.; Kap, M.; Kwekkeboom, J.; Ijzermans, J.N.M.; Tilanus, H.W.; et al. Are Cytokine Gene Polymorphisms Related to in Vitro Cytokine Production Profiles? Liver Transpl. 2003, 9, 170–181. [Google Scholar] [CrossRef]
- Patel, J.A.; Nair, S.; Ochoa, E.E.; Huda, R.; Roberts, N.J.; Chonmaitree, T. Interleukin-6−174 and Tumor Necrosis Factor A−308 Polymorphisms Enhance Cytokine Production by Human Macrophages Exposed to Respiratory Viruses. J. Interferon Cytokine Res. 2010, 30, 917–921. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, W.; Shi, W.; Yin, Y.; Chen, J.; Luo, L. Association of IL-17 and IL-23 Gene Variants with Plasma Levels and Risk of Vulvovaginal Candidiasis in a Chinese Han Population. Pharmgenomics Pers. Med. 2020, 13, 725–733. [Google Scholar] [CrossRef]
- García-Ramírez, R.A.; Ramírez-Venegas, A.; Quintana-Carrillo, R.; Camarena, Á.E.; Falfán-Valencia, R.; Mejía-Aranguré, J.M. TNF, IL6, and IL1B Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in the Mexican Population. PLoS ONE 2015, 10, e0144832. [Google Scholar] [CrossRef] [Green Version]
- Keshavarz, M.; Namdari, H.; Farahmand, M.; Mehrbod, P.; Mokhtari-Azad, T.; Rezaei, F. Association of Polymorphisms in Inflammatory Cytokines Encoding Genes with Severe Cases of Influenza A/H1N1 and B in an Iranian Population. Virol. J. 2019, 16, 79. [Google Scholar] [CrossRef]
- Romanova, E.N.; Govorin, A.V. [TNF-α, IL-10, and eNOS gene polymorphisms in patients with influenza A/H1N1 complicated by pneumonia]. Ter Arkh 2013, 85, 58–62. [Google Scholar]
- Zhou, J.; To, K.K.-W.; Dong, H.; Cheng, Z.-S.; Lau, C.C.-Y.; Poon, V.K.M.; Fan, Y.-H.; Song, Y.-Q.; Tse, H.; Chan, K.-H.; et al. A Functional Variation in CD55 Increases the Severity of 2009 Pandemic H1N1 Influenza A Virus Infection. J. Infect. Dis. 2012, 206, 495–503. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Frade, A.F.; de Oliveira, L.C.; Costa, D.L.; Costa, C.H.N.; Aquino, D.; Van Weyenbergh, J.; Barral-Netto, M.; Barral, A.; Kalil, J.; Goldberg, A.C. TGFB1 and IL8 Gene Polymorphisms and Susceptibility to Visceral Leishmaniasis. Infect. Genet. Evol. 2011, 11, 912–916. [Google Scholar] [CrossRef]
- Wu, F.; Qu, Y.; Tang, Y.; Cao, D.; Sun, P.; Xia, Z. Lack of Association between Cytokine Gene Polymorphisms and Silicosis and Pulmonary Tuberculosis in Chinese Iron Miners. J. Occup. Health 2008, 50, 445–454. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Warzocha, K.; Ribeiro, P.; Bienvenu, J.; Roy, P.; Charlot, C.; Rigal, D.; Coiffier, B.; Salles, G. Genetic Polymorphisms in the Tumor Necrosis Factor Locus Influence Non-Hodgkin’s Lymphoma Outcome. Blood 1998, 91, 3574–3581. [Google Scholar] [CrossRef]
- Kinnunen, A.H.; Surcel, H.-M.; Lehtinen, M.; Karhukorpi, J.; Tiitinen, A.; Halttunen, M.; Bloigu, A.; Morrison, R.P.; Karttunen, R.; Paavonen, J. HLA DQ Alleles and Interleukin-10 Polymorphism Associated with Chlamydia Trachomatis-Related Tubal Factor Infertility: A Case-Control Study. Hum. Reprod. 2002, 17, 2073–2078. [Google Scholar] [CrossRef] [PubMed]
- Perrey, C.; Turner, S.J.; Pravica, V.; Howell, W.M.; Hutchinson, I.V. ARMS-PCR Methodologies to Determine IL-10, TNF-Alpha, TNF-Beta and TGF-Beta 1 Gene Polymorphisms. Transpl. Immunol. 1999, 7, 127–128. [Google Scholar] [CrossRef]
- Solé, X.; Guinó, E.; Valls, J.; Iniesta, R.; Moreno, V. SNPStats: A Web Tool for the Analysis of Association Studies. Bioinformatics 2006, 22, 1928–1929. [Google Scholar] [CrossRef] [Green Version]
- Choudhary, M.L.; Alagarasu, K.; Chaudhary, U.; Kawale, S.; Malasane, P.; Gurav, Y.K.; Padbidri, V.; Kadam, D.; Sangle, S.A.; Salvi, S.; et al. Association of Single Nucleotide Polymorphisms in TNFA and IL10 Genes with Disease Severity in Influenza A/H1N1pdm09 Virus Infections: A Study from Western India. Viral. Immunol. 2018, 31, 683–688. [Google Scholar] [CrossRef]
- Hagau, N.; Slavcovici, A.; Gonganau, D.N.; Oltean, S.; Dirzu, D.S.; Brezoszki, E.S.; Maxim, M.; Ciuce, C.; Mlesnite, M.; Gavrus, R.L.; et al. Clinical Aspects and Cytokine Response in Severe H1N1 Influenza A Virus Infection. Crit. Care 2010, 14, R203. [Google Scholar] [CrossRef] [Green Version]
- Almansa, R.; Anton, A.; Ramirez, P.; Martin-Loeches, I.; Banner, D.; Pumarola, T.; Xu, L.; Blanco, J.; Ran, L.; Lopez-Campos, G.; et al. Direct Association between Pharyngeal Viral Secretion and Host Cytokine Response in Severe Pandemic Influenza. BMC Infect. Dis. 2011, 11, 232. [Google Scholar] [CrossRef]
- Yu, X.; Zhang, X.; Zhao, B.; Wang, J.; Zhu, Z.; Teng, Z.; Shao, J.; Shen, J.; Gao, Y.; Yuan, Z.; et al. Intensive Cytokine Induction in Pandemic H1N1 Influenza Virus Infection Accompanied by Robust Production of IL-10 and IL-6. PLoS ONE 2011, 6, e28680. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Martinez-Ocaña, J.; Olivo-Diaz, A.; Salazar-Dominguez, T.; Reyes-Gordillo, J.; Tapia-Aquino, C.; Martínez-Hernández, F.; Manjarrez, M.E.; Antonio-Martinez, M.; Contreras-Molina, A.; Figueroa-Moreno, R.; et al. Plasma Cytokine Levels and Cytokine Gene Polymorphisms in Mexican Patients during the Influenza Pandemic A(H1N1)Pdm09. J. Clin. Virol. 2013, 58, 108–113. [Google Scholar] [CrossRef]
- Paquette, S.G.; Banner, D.; Zhao, Z.; Fang, Y.; Huang, S.S.H.; Leόn, A.J.; Ng, D.C.K.; Almansa, R.; Martin-Loeches, I.; Ramirez, P.; et al. Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A Infection. PLoS ONE 2012, 7, e38214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Arriaga-Pizano, L.; Ferat-Osorio, E.; Rodríguez-Abrego, G.; Mancilla-Herrera, I.; Domínguez-Cerezo, E.; Valero-Pacheco, N.; Pérez-Toledo, M.; Lozano-Patiño, F.; Laredo-Sánchez, F.; Malagón-Rangel, J.; et al. Differential Immune Profiles in Two Pandemic Influenza A(H1N1)Pdm09 Virus Waves at Pandemic Epicenter. Arch. Med. Res. 2015, 46, 651–658. [Google Scholar] [CrossRef] [Green Version]
- Croker, B.A.; Krebs, D.L.; Zhang, J.-G.; Wormald, S.; Willson, T.A.; Stanley, E.G.; Robb, L.; Greenhalgh, C.J.; Förster, I.; Clausen, B.E.; et al. SOCS3 Negatively Regulates IL-6 Signaling in Vivo. Nat. Immunol. 2003, 4, 540–545. [Google Scholar] [CrossRef]
- Yasukawa, H.; Ohishi, M.; Mori, H.; Murakami, M.; Chinen, T.; Aki, D.; Hanada, T.; Takeda, K.; Akira, S.; Hoshijima, M.; et al. IL-6 Induces an Anti-Inflammatory Response in the Absence of SOCS3 in Macrophages. Nat. Immunol. 2003, 4, 551–556. [Google Scholar] [CrossRef]
- Zhu, S.; Zeng, C.; Zou, Y.; Hu, Y.; Tang, C.; Liu, C. The Clinical Diagnostic Values of SAA, PCT, CRP, and IL-6 in Children with Bacterial, Viral, or Co-Infections. Int. J. Gen. Med. 2021, 14, 7107–7113. [Google Scholar] [CrossRef] [PubMed]
- Viasus, D.; Paño-Pardo, J.R.; Pachón, J.; Campins, A.; López-Medrano, F.; Villoslada, A.; Fariñas, M.C.; Moreno, A.; Rodríguez-Baño, J.; Oteo, J.A.; et al. Factors Associated with Severe Disease in Hospitalized Adults with Pandemic (H1N1) 2009 in Spain. Clin. Microbiol. Infect. 2011, 17, 738–746. [Google Scholar] [CrossRef] [Green Version]
Demographic Characteristics | Mild Cases (n = 293) | Severe Cases (n = 86) | p-Value |
---|---|---|---|
Age [mean years ± standard deviation] Males [n (%)] Females [n (%)] | 39.1 ± 18.0 144 (49.1%) 149 (50.8%) | 50.0 ± 13.0 46 (53.5%) 40 (46.5%) | <1 × 10−6 − 0.6447 |
SNP | Alleles | Percent Minor Allele Frequency n(%) A | Mild Cases vs. Severe Cases/Severe Survived Cases/Fatal Cases | |
---|---|---|---|---|
Odds Ratio (95% CI) | p-Value | |||
IL6 rs1800795 Mild cases Severe cases Survived severe cases Fatal cases TNFA rs1800629 Mild cases Severe cases Survived severe cases Fatal cases INFGrs2430561 Mild cases Severe cases Survived severe cases Fatal cases IL17A rs2275913 Mild cases Severe cases Survived severe cases Fatal cases IL10 rs1800896 Mild cases Severe cases Severe survived cases Fatal cases IL10 rs1800872 Mild cases Severe cases Severe survived cases Fatal cases TGFB rs1800470 Mild cases Severe cases Severe survived cases Fatal cases TGFBrs1800471 Mild cases Severe cases Severe survived cases Fatal cases | G>C G>A A>T G>A G>A C>A T>C G>C | 75 (12.8) 22 (12.8) 10 (11.1) 12 (14.6) 27 (4.6) 20 (13.1) 13 (14.4) 7 (8.2) 218 (37.2) 61 (35.4) 25 (27.8) 36 (43.9) 220 (39.1) 58 (34.1) 31 (35.2) 27 (32.9) 150 (25.6) 40 (23.2) 23 (25.5) 17 (20.7) 252 (43.0) 80 ( 46.5) 42 (46.7) 38 (46.3) 278 (47.6) 80 (47.0) 43 (47.8) 37 (46.2) 45 (7.7) 16 (9.7) 8 (8.9) 8 (9.7) | − 0.99 (0.59–1.64) 0.85 (0.40–1.66) 1.16 (0.58–2.20) − 2.72 (1.47–4.99) 3.49 (1.68–6.99) 1.93 (0.75–4.45) − 0.93 (0.65–1.32) 0.65 (0.39–1.05) 1.32 (0.82–2.11) − 0.85 (0.59–1.22) 0.89 (0.55–1.42) 0.81 (0.49–1.31) − 0.88 (0.59–1.31) 0.99 (0.59–1.65) 0.76 (0.42–1.32) − 1.15 (0.82–1.62) 1.16 (0.74–1.81) 1.14 (0.72–1.82) − 0.98 (0.69–1.38) 1.01 (0.64–1.57) 0.95 (0.59–1.51) − 1.23 (0.66–2.22) 1.17 (0.50–2.50) 1.30 (0.55–2.78) | − 0.999 0.668 0.639 − 0.002 0.001 0.155 − 0.682 0.081 0.246 − 0.384 0.649 0.397 − 0.539 0.994 0.346 − 0.416 0.515 0.569 − 0.901 0.974 0.823 − 0.489 0.672 0.508 |
SNP and Genotypes | Genotypic Count (%) in | Mild vs. Severe Cases | Mild vs. Severe Survived Cases | Mild vs. Fatal Cases | |||
---|---|---|---|---|---|---|---|
Mild Cases | Severe Cases | Survived Severe Cases | Fatal Cases | Odds Ratio with 95% Confidence Intervals | |||
IL6 rs1800795 G/G G/C C/C TNFA rs1800629 G/G G/A INFGrs2430561 A/A A/T T/T IL17A rs2275913 G/G G/A A/A IL10 rs1800896 A/A A/G G/G IL10 rs1800872 C/C C/A A/A TGFB rs1800470 T/T T/C C/C TGFBrs1800471 G/G G/C | 224 (76.7) 61 (20.9) 7 (2.4) 266 (90.8) 27 (9.2) 114 (38.9) 140 (47.8) 39 (13.3) 115 (39.5) 132 (45.4) 44 (15.1) 168 (57.3) 100 (34.1) 25 (8.4) 101 (34.5) 132 (45.0) 60 (20.0) 87 (29.8) 132 (45.2) 73 (25.0) 248 (84.6) 45 (15.4) | 65 (75.6) 20 (23.3) 1 (1.2) 66 (76.7) 20 (23.3) 34 (39.5) 43 (50.0) 9 (10.5) 40 (47.1) 32 (37.6) 13 (15.3) 55 (64.0) 22 (25.6) 9 (10.5) 22 (25.6) 48 (55.8) 16 (18.6) 25 (29.4) 40 (47.1) 20 (23.5) 70 (81.4) 16 (18.6) | 35 (77.8) 10 (22.2) 0 32 (71.1) 13 (28.9) 23 (51.1) 19 (42.2) 3 (6.7) 20 (45.5) 17 (38.6) 7 (15.9) 28 (62.2) 11 (24.4) 6 (13.3) 12 (26.7) 24 (53.3) 9 (20.0) 13 (28.9) 21 (46.7) 11 (24.4) 37 (82.2) 8 (17.8) | 30 (73.2) 10 (24.4) 1 (2.4) 34 (82.9) 7 (17.1) 11 (26.8) 24 (58.5) 6 (14.6) 20 (48.8) 15 (36.6) 6 (14.6) 27 (65.8) 11 (26.8) 3 (7.3) 10 (24.4) 24 (58.5) 7 (17.1) 12 (30.0) 19 (47.5) 9 (22.5) 33 (80.5) 8 (19.5) | 1.00 1.14 (0.63–2.07) 0.80 (0.10–6.77) 1.00 2.95 (1.52–5.73) * 1.00 1.08 (0.63–1.84) 0.94 (0.40–2.19) 1.00 0.72 (0.42–1.24) 0.87 (0.41–1.85) 1.00 0.63 (0.35–1.1) 0.94 (0.40–2.21) 1.00 1.77 (0.98–3.21) 1.50 (0.71–3.18) 1.00 1.06 (0.59–1.91) 0.86 (0.43–1.73) 1.00 1.21 (0.63–2.32) | 1.00 1.02 (0.47–2.21) 0.00 1.00 4.02 (1.84–8.82) @ 1.00 0.67 (0.34–1.31) 0.46 (0.13–1.66) 1.00 0.81 (0.40–1.65) 0.97 (0.37–2.50) 1.00 0.62 (0.29–1.32) 1.29 (0.47–3.54) 1.00 1.61 (0.75–3.45) 1.50 (0.58–3.88) 1.00 1.06 (0.50–2.28) 0.97 (0.40–2.35) 1.00 1.15 (0.49–2.68) | 1.00 1.28 (0.58–2.81) 1.76 (0.20–15.31) 1.00 2.04 (0.80–5.17) 1.00 1.85 (0.85–4.03) 2.04 (0.68–6.10) 1.00 0.67 (0.32–1.39) 0.79 (0.29–2.18) 1.00 0.61 (0.28–1.33) 0.60 (0.16–2.21) 1.00 1.95 (0.87–4.36) 1.47 (0.51–4.18) 1.00 1.07 (0.49–2.37) 0.79 (0.31–2.02) 1.00 1.30 (0.55–3.09) |
Haplotypes | Percent Predicted Haplotype | Mild vs. Severe Cases | Mild vs. Severe Survived Cases | Mild vs. Fatal Cases | |||
---|---|---|---|---|---|---|---|
Mild Cases | Severe Cases | Severe Survived Cases | Fatal Cases | Odds Ratio with 95% Confidence Intervals | |||
IL10 rs1800896-rs1800872 A-A A-C G-C G-A TGFB rs1800470-rs1800471 T-G C-G C-C T-C | 41.9 32.5 24.5 1.1 50.8 41.5 6.1 1.6 | 43.2 33.6 19.9 3.3 49.9 40.8 6.2 3.1 | 45.3 29.2 24.2 1.4 48.0 43.1 4.7 4.2 | 39.4 39.9 13.8 7.0 51.8 38.4 7.7 2.00 | 1.00 0.92 (0.60–1.40) 0.66 (0.41–1.07) 3.21 (0.75–13.69) 1.00 0.98 (0.68–1.40) 0.87 (0.36–2.12) 2.84 (0.60–13.50) | 1.00 0.77 (0.44–1.34) 0.83 (0.48–1.45) 1.19 (0.12–11.98) 1.00 1.08 (0.68–1.71) 0.68 (0.17–2.65) 3.91 (0.67–22.86) | 1.00 1.25 (0.69–2.25) 0.34 (0.12–0.95) * 12.11 (2.23–76.96) @ 1.00 0.88 (0.55–1.43) 1.12 (0.39–3.24) 1.74 (0.17–18.18) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alagarasu, K.; Kaushal, H.; Shinde, P.; Kakade, M.; Chaudhary, U.; Padbidri, V.; Sangle, S.A.; Salvi, S.; Bavdekar, A.R.; D’costa, P.; et al. TNFA and IL10 Polymorphisms and IL-6 and IL-10 Levels Influence Disease Severity in Influenza A(H1N1)pdm09 Virus Infected Patients. Genes 2021, 12, 1914. https://doi.org/10.3390/genes12121914
Alagarasu K, Kaushal H, Shinde P, Kakade M, Chaudhary U, Padbidri V, Sangle SA, Salvi S, Bavdekar AR, D’costa P, et al. TNFA and IL10 Polymorphisms and IL-6 and IL-10 Levels Influence Disease Severity in Influenza A(H1N1)pdm09 Virus Infected Patients. Genes. 2021; 12(12):1914. https://doi.org/10.3390/genes12121914
Chicago/Turabian StyleAlagarasu, Kalichamy, Himanshu Kaushal, Pooja Shinde, Mahadeo Kakade, Urmila Chaudhary, Vikram Padbidri, Shashikala A. Sangle, Sonali Salvi, Ashish R. Bavdekar, Pradeep D’costa, and et al. 2021. "TNFA and IL10 Polymorphisms and IL-6 and IL-10 Levels Influence Disease Severity in Influenza A(H1N1)pdm09 Virus Infected Patients" Genes 12, no. 12: 1914. https://doi.org/10.3390/genes12121914